Polyethylene Glycol 8000 from GE Healthcare, formerly Amersham Biosciences

Polypropylene Plate Cover with stacking ridge from ABgene

Polypropylene Plate Cover from ABgene

...e components including positive and negative contr...tion in cultured cells and tissue sections. The in...ter sensitivity than biotinylated or digoxigenylat...try. The kit works well with GFP transfected cells...

SYBRGreen I nucleic acid gel stain from Sigma-Aldrich

Biology Products:

Polypropylene Plate Cover with stacking ridge from ABgene Polypropylene Plate Cover from ABgene ApoBrdU Red DNA Fragmentation Kit from MBL International SYBRGreen I nucleic acid gel stain from Sigma-Aldrich

(Date:11/6/2009)...6 Auburn Hills, MI-based Law Enfor...talling its locker system and patent-pending Biome...Department of Health and Human Services, National ... The locker system will support the NIH,s entire p... nation,s medical research agency. The project is...

(Date:11/5/2009)...ity has been awarded a training grant in the amoun... under its Integrative Graduation Education and Re... IGERT grant to be awarded to Kent State. The gran... Reinvestment Act of 2009, runs through 2014. , ...nvironment aquatic resource sensing (EARS). The pu...

(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....

Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2 TV bombards children with commercials for high-fat and high-sugar foods 2 TV bombards children with commercials for high-fat and high-sugar foods 3 Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 1 Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 2 Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 3 Senate Bill to Protect Patients Healthcare by Amending Medicare Coverage 48578 1 Senate Bill to Protect Patients Healthcare by Amending Medicare Coverage 48578 2 Senate Bill to Protect Patients Healthcare by Amending Medicare Coverage 48578 3 Medivation Completes Enrollment in Confirmatory Pivotal Phase 3 CONNECTION Trial of Dimebon in Patients With Alzheimers Disease 12580 1 Medivation Completes Enrollment in Confirmatory Pivotal Phase 3 CONNECTION Trial of Dimebon in Patients With Alzheimers Disease 12580 2 Medivation Completes Enrollment in Confirmatory Pivotal Phase 3 CONNECTION Trial of Dimebon in Patients With Alzheimers Disease 12580 3 Medivation Completes Enrollment in Confirmatory Pivotal Phase 3 CONNECTION Trial of Dimebon in Patients With Alzheimers Disease 12580 4

[0] National Institutes of Health Secures Armory with Patent-Pending Technology [0] Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing [0] TV bombards children with commercials for high-fat and high-sugar foods

...us maculates, a fairly abundant species of grouper...of microscopic monogenean worms. This diversity of...abar grouper, Epinephilus malabaricus, another the...iversity prevails in all coral-reef fish, tens of ...m waiting to be discovered., , In the same way as...

... "biotechnology" elicits a range of emotions, from...en from the University of California in Riverside ...ublic knowledge of biotech, popular misperceptions... How is coexistence dealt with in the US and Europ...g companies or also the society at large" In the p...

...ger marsupial thylacine by being better built anat...ted with killing large prey, say Australian scient...and efficient bite and having larger energy needs ...ting relatively small prey while the dingo,s stron...ge prey as well. , Earlier studies had given ambi...

Other Biology News:Coral reef fish harbor an unexpectedly high biodiversity of parasites 2 Coral reef fish harbor an unexpectedly high biodiversity of parasites 3 How the public perceives biotech 2 Tassie tiger no match for dingo 2

Coral reef fish harbor an unexpectedly high biodiversity of parasites How the public perceives biotech Tassie tiger no match for dingo

(Date:11/5/2009)...ROOK, N.Y., Nov. 5 BioSp...pharmaceutical company developing first-in-class c...ancial results for the third quarter ended Septemb... in September of this year, the FDA,s Arthritis Ad...e of 12-0, the approval of XIAFLEX(TM) for the tre...

(Date:11/5/2009)... WORTH, Texas, Nov. 5 Wo...ed today that it has entered into a Letter of Inte...rtual Health Technologies, Inc. (OTC Bulletin Boar...,000,000 in cash and debt, 4,000,000 shares of WND...y WNDM on the Veriscrip technology being acquired ...

(Date:11/5/2009)...ONT, Calif., Nov. 5 Wafe...a leading developer of state-of-the-art genetic an...ears, Ph.D. has joined the company,s Scientific Ad...gning and commercializing novel molecular diagnost...nd on the development of computational biology sys...

(Date:11/5/2009)...PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-Fir... ) ("BMP Sunstone" or the "Company") today announc... 2009 financial results on,Monday, November 9, 200... will hold a conference call at 5:00 pm ET on Nove.... Listeners may access the call by,dialing 1-888-...

Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4 BMP Sunstone to Report Third Quarter 2009 Financial Results 2

[0] BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results [0] OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock [0] WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board [0] BMP Sunstone to Report Third Quarter 2009 Financial Results